Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

KPTIKPTI

Showing 0 of 21 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in Karyopharm Therapeutics Inc.

No. MetLife Investment Management exited its KPTI (Karyopharm Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 60,551 shares worth $91,432. MetLife Investment Management first reported KPTI in Q2 2019 and held it in 19 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used